.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recently, Philips and Apollo Hospitals signed a Memorandum of Understanding (MoU) to enhance stroke and heart care across India. This strategic partnership aims to address the growing burden of cardiovascular and neurological diseases. Consequently, the collaboration will focus on technology-enabled pathways for faster diagnosis and intervention. Clinicians will benefit from integrated decision-making tools for complex, time-sensitive cases.
India reported approximately 1.25 million new stroke cases in 2021. This figure represents a significant increase compared to data from 1990. Additionally, cardiovascular diseases remain the leading cause of mortality in India. Therefore, the partnership prioritizes precision imaging and faster interventions. The goal is to reduce the \"door-to-needle\" time for stroke patients. Consequently, this focus could significantly improve survival rates during the critical \"golden hour.\"
The collaboration leverages advanced imaging and image-guided therapy. Specifically, the teams aim to optimize contrast usage and procedural accuracy in structural heart disease. Furthermore, streamlined workflows will likely enhance overall clinical efficiency. Roy Jakobs, CEO of Royal Philips, emphasized the need for data-driven, resilient care pathways. Similarly, Dr. Prathap C. Reddy noted that advanced technology is vital for scalable healthcare. Ultimately, this initiative seeks to deliver high-quality care to a larger patient population.
Q1: What are the primary focus areas of the Philips-Apollo collaboration?
The partnership specifically targets two clinical areas: structural heart disease management and stroke care workflows in India.
Q2: How will this initiative help stroke patients in India?
The initiative aims to accelerate imaging workflows and streamline patient pathways. This ensures interventions occur within the critical \"golden hour\" to improve clinical outcomes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Philips and Apollo Hospitals sign an MoU to enhance stroke and structural heart disease management in India through advanced imaging and integrated care....
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
